Estudio en fase II de Nevelbine + Cisplatino + etopósido en el tratamiento de cáncer de pulmón no células pequeñas inoperable
DOI:
https://doi.org/10.31053/1853.0605.v53.n1.40661Keywords:
.Abstract
40 patients with advanced non-small cell luna cancer lot previously treated were included in a study at puase II with vinorelbine 20 mg/Sq.m days 1 and 8, etoposide 60 mg/sq.m days 1-3 and cisplatin 75 mg/sq.m day 1 1 each 28 days for 6 cycles.
There were 31 iiien and 9 women, being the average age of 54 years, with "performance Status" grade 0-2. Al! of theni could be cvaluated for toxicity and 31 for responsiveness. 10 patients were 11 stage ilib and 21 at stage W. 42% of objective responses 'ere obtained and an overa!] survival of 9 iionths, which justifies fiirther studies.
Downloads
References
Belani Ch: Multimodalitv Management of Regional])' Advenccd Non-Small Ce!] Lung Cancer. Sem in Oncol 4:302-314, 1993.
Berihaud 11. LeChevalierI'. RufficP: Phase 1-11 study of Vinorelbine (Navelbine) plus Cisplatio in Advanced non sinali ce]l lung cancer. [tir J Cancer 28(11):1863-18651 1992.
Bitran .1 D. Desscr R K. De Mecster T: Metatastic non-coat ce!! bronchogenic carcinoma. CanccrTreat Rep62: 1595-1597. 1978.
Bonomi P D, Finke!stein DM. Ruckdesche! .1 C: Combination chenioiherapy versus single agent fol!owed by combination chemotherapy in stage IV non-snia!l ce]l lung cancer: A study o!' thc Eastern
Cooperativc Oncology Group. .1 Clin Onco] 7:1602-1613. 1989.
Boring C C. Squires T S. Tong T: Cancer StatisticsCA. Canceri Clin42: 19-43, 1992.
Cellcrino R,Tumm arel lo D. Porflri E:Non- sma!l ce]l long cancer. A prospective random i ied trial vith alternati n chcmotherapy CEP/MEC versos non treatnlent. Eur J Cancer Clin Oncol 24:1839- 1843. 1988.
Chainian A P. Mande! E M. Ho!land J E: MACC (methotrexate adriamicyn. cvclophospliam ide. and CCN U) o advanced Ring cancer. Cancer 43: 1590-1597. 1979.
DcpierreA. Lcmarié E. DahouisG: A phase II study of Navelbin (vinore!hine) jo the trcalnient of non-sial 1 ce!] long cancer. Am j Clin Onco! 14:115-119. 1991.
Di!lman R. Seagren S. Propert K A: Random ized tria! ofinduction chemotherapy plus high dose radiation versos radiation alone in stage III non-small ccll luna cancer. N Engl .1 Mcd. 940-945, 1990.
Donriadieu N. Paesnians M, Scolier J: Chemotherapy ofnon-smal 1 canceraccording tu discase cxtent: A meta-analysis of Ihe literature. Long Cancer 7:243-252, 1991.
Eagan R F. Ingle .1 N. Frytak S: Platinum- hased po! ych cmoth erapy ve rs LIS dianhvdrogalactitol in avanced non-smalI ce!] long cancer. Cancer Trcat Rep 61:1339- 1345. 1977.
¡2. Einhorn L II. Loerher P i. Williams S D: Random prospective study of vindesine versos vindesine plus high-dose cisplatin plus mitomycin C in aclvanced non-small ccl] long caricer. J Clin Onco! 7:1037-1043. 1986.
Epidemiology Cancer Statistics. CA. 41:19- 36. 1991.
Evans V K. Fcld R. DeBoer G: Ciclophosphamide. doxorrubicin. and cisplatin iii thc treattnent of non-small ccll bronchogenic carcinoma. Canccri'reat Rep 65:941-945, 1981.
Fernandez O. Bruno .1. Mickiewicz E: Randomized comparison ot'navelbin (NVB) and cisplatin (CDDP) versos navelin alone o patients with inoperable non-sinall ccli long carcinoma (NSCLC). Proc 15111
Internationa! Cancer Congress. .1 Cancer Res Clin Oncol. V 1 16:Supp!, 1990. Ganz P A. Fig!in R A. Haskel! C Ni: Supportive versos sopportive care and combinalion cheniotherapy in metastatic non-sma!! ce]] lung cancer. Cancer63:1271- 1278. 1989.
Gralla RL CasperES. Kelscn D P: Cisplatin and vinclesin combination cheniotherapy for advanced carcinoma of lung: A randomized ¡rial investigatinglwoschedu!es. Ano lotero Mcd 95:414-420. 1981.
Greco M, Stoopler Ni, Anderson Vinblastine (V) and cisplastin (CDDP) chemotherapy in advanced non-sia!I ccli long cancer (NSCLC). Proc Ani Clin Oncol 4:176. 1985.
Kaasa S. Luod E. Thornd E: Symptomatie treatment vesus combination chemotherapv for patients with cxtensivc non-small ce!l long cancer. Cancer 67:2443-2447. 1991.
Klastersky J: 'I'herapv kxitli cisplastin and etoposide for non-sniall eclI long cancer. Semin Onco! 1 (suppl 3)13:104-114, 1986.
Knost .1 A. Greco E A, Hande K R: Ciclophosphamide. doxorruhicin, and cisplatin in the treatnient of advanccd nonsmall ce!l long cancer. Cancer 'Freat Rep 61:1339-1345, 1977.
Kris M. Cohen E. Gralla R: An analysis of 134 phase 11 trials in non-sma!l ce!l long cancer. Proc IV World Conf Long Cancer 4:39, 1985 (abstr.).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Universidad Nacional de Córdoba
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The Faculty of Medical Sciences Journal (RFCM) subscribes to the Open Access policy and does not charge authors fees for publishing, nor does it charge readers fees for accessing published articles (APC).
